0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

The Effects of Triparanol (MER-29) in Subjects with and without Coronary Artery Disease

William Hollander, M.D.; Aram V. Chobanian, M.D.; Robert W. Wilkins, M.D.
JAMA. 1960;174(1):5-12. doi:10.1001/jama.1960.03030010007002.
Text Size: A A A
Published online

Triparanol, an inhibitor of cholesterol biosynthesis, significantly reduced the serum cholesterol in 71 of 89 subjects with and without hypercholesterolemia. The compound in a maximally effective dose of 250 mg. per day was well tolerated and caused no serious side effects. The decrease in serum cholesterol (Abell) averaged 45 mg. % and ranged from 20 to 110 mg. %. The ratio of serum cholesterol to serum phospholipid also was favorably influenced by therapy.

Triparanol, as indicated by radioisotopic tracer studies, also appeared to reduce the total sterol and cholesterol content of the body by decreasing the formation of cholesterol the body.

The compound appeared to have an anti-anginal effect in 12 of 28 subjects and to improve the electrocardiographic responses to exercise in 3 of 11 subjects with angina pectoris. These effects were associated with a fall in serum cholesterol.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();